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Abstract The sequence of a gene from Bombina orientalis was
determined which codes for antibacterial peptides. The gene
comprises two exons separated by a large intron. Exon 1 codes
for the signal peptide, while exon 2 contains the genetic
information for two identical bombinins and one bombinin H.
The promoter region of the bombinin gene contains putative
recognition sites for nuclear factors, such as NFUB and NF-IL6.
In vivo experiments on B. orientalis have shown that a short
contact with bacteria is sufficient to induce a marked increase in
the amount of antibacterial peptides in the skin secretion of
frogs. This increase was suppressed by pretreatment with
glucocorticoids. In the latter case, a significant increase of
IUBK in the secretion is also detectable.
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1. Introduction
Many immunity related genes are under the dual control of
the rel-containing transcription factor NFUB and di¡erent in-
hibitors called IUBs, all with ankyrin repeats [1]. In mamma-
lian cell cultures, it has been demonstrated that glucocorti-
coids (GCs) induce a dramatic synthesis of IUBK but not
related forms of this inhibitor. These increased levels of
IUBK prevent the translocation of NFUB to the nucleus,
thus blocking the transcription of genes with promoter sites
for NFUB binding [2,3]. This observation could explain the
potent immunosuppressive activity exerted by GCs.
Recently, we have demonstrated by HPLC analysis that
treatment of the skin of the frog Rana esculenta with a cream
containing a glucocorticoid inhibited all de novo synthesis of
the antibacterial peptides normally present in the skin secre-
tion [4]. Moreover, Northern blot analysis of total RNA from
the skin showed that all mRNAs for the precursors of anti-
bacterial peptides were absent. In addition, immunoblot anal-
ysis of the cytoplasmic skin proteins showed a clear rise of
IUBK, detected with an antibody against human IUBK [4].
These results suggest that Rana frogs in vivo regulate their
peptide-mediated innate immunity by an NFUB/IUBK-like
mechanism. So far, all mammalian genes encoding antibacte-
rial peptides have been found to contain promoter motifs that
potentially bind NFUB-like factors [5^9], but no functional
studies have yet been reported. In contrast, Drosophila has
become a model system for both in vitro and in vivo studies
of the molecular mechanisms behind the NFUB/IUBK regula-
tion [10,11]. In insects, this type of mechanism is used for
control of both immunity and development [10^13].
In order to verify the immunity related function of the
NFUB/IUBK complex in another amphibian species, we have
started an investigation of the frog Bombina orientalis to de-
termine the structure of genes encoding bombinin-like antimi-
crobial peptides in this species.
In 1970, bombinin was described as an antibacterial and
hemolytic peptide isolated from the skin of Bombina variegata
[14]. More recently, isolation of peptides and cDNA clones
from B. variegata [15] and B. orientalis [16] showed that the
original bombinin was in fact a mixture of peptides, then
referred to as bombinin-like peptides (BLP). Some of these
peptides were both antibacterial and hemolytic, others had
only one or the other of these functions. Some of the peptides
from B. variegata with both functions turned out to have a D-
amino acid in position 2 [17], as a result of a post-transla-
tional modi¢cation reaction, recently reviewed [18].
The goal of the present study was to understand factors
that can up- or down-regulate the activity of the genes for
antimicrobial peptides. Two genes from B. orientalis have
been sequenced; the ¢rst gene contains an open reading frame
coding for two copies of BLP-3 [16] and a new peptide GH-1.
Interestingly, regions involved with the recognition of nuclear
factors were identi¢ed upstream of this gene. The other gene is
of similar design, but contains the information for a single
copy of a bombinin-like peptide and another new peptide,
GH-2. Experiments on the induction of the genes in live ani-
mals as well as the inhibition of induction by glucocorticoids
are also reported.
2. Materials and methods
2.1. DNA preparation and genomic library construction
High molecular weight genomic DNA was isolated from the liver of
B. orientalis (an adult male of 5 g), using a Qiagen DNA kit. The
fragments produced by partial digestion of this DNA with Sau3a were
fractionated by centrifugation on a 10^40% sucrose gradient [19].
Fractions containing the 12^23-kb fragments were collected. After
ethanol precipitation, the sized DNAs were partially ¢lled in using
dATP and dGTP to create ends compatible with those of V Fix II
supplied in the V Fix II/XhoI partial ¢ll-in vector kit (Stratagene). The
ligated DNAs were packaged in vitro using the protocol and the
reagent supplied with Gigapack II Gold packaging system (Strata-
gene). Ampli¢cation of the library was performed according to the
manufacturer’s instructions.
2.2. Screening of genomic library
Part of the library (5U105 clones) was screened following the pro-
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cedure of Benton and Davis [20]. The Nytran-Plus ¢lters (Schleicher
and Schuell) were probed with a full-length cDNA encoding the com-
plete precursor of bombinin (clone 42 from B. variegata [15]), labelled
by random priming with [K-32P]dCTP (3000 Ci/mmol). Hybridization
was carried out for 18 h at 42‡C in 2 mM sodium phosphate bu¡er,
pH 7.2, containing 50% formamide, 5U SSPE (150 mM NaCl, 10 mM
sodium phosphate bu¡er, pH 7.0, 1 mM EDTA), 5U Denhart’s sol-
ution, 0.5% SDS and 100 Wg/ml herring sperm DNA. Filters were then
washed at 50‡C for 20 min in 0.1U SSPE, 0.1% SDS and exposed for
8 h on Kodak X-Omat SO 282 ¢lms with an intensifying screen at
380‡C. Positive clones were puri¢ed by repeated plating and hybrid-
ization until 100% of the phages were positive.
2.3. Subcloning and sequencing
The restriction maps of two strongly positive clones (termed B9 and
B24) were obtained with single and multiple complete digestions with
HindIII, BamHI and SacI. The genomic DNA in B24 was digested
with SacI, and 8-, 6.5-, 3.5-, and 2-kb fragments were obtained.
Southern analysis of these fragments showed that only the 6.5-kb
fragment hybridized to the cDNA probe. The positive fragment was
subcloned into pBluescript vector (Stratagene). The nucleotide se-
quence was determined on both strands either by the chain termina-
tion method using Sequenase kit (USB) or by automated £uorescent
DNA sequencing (MediGene AG, Germany) with pBluescript univer-
sal or gene-speci¢c primers.
The genomic DNA of clone B9 gave a 15-kb SacI-SacI fragment. It
was digested with HindIII yielding several sub-fragments, of which
only the 1.5- and 1.0-kb sub-fragments were found to hybridize to
the cDNA probe. These fragments were subcloned into pBluescript
and sequenced as above.
2.4. Glucocorticoid treatment of frogs and immunoblotting
Four B. orientalis frogs (about 10 g each) were initially given a mild
electrical stimulation (8 V for 15 s at three equal intervals) to obtain a
complete discharge of the cutaneous glands, and then kept in a terra-
rium for three weeks. After this period, two of them were injected
with a 25-Wg methylprednisolone solution (Solu-Medrol, Upjohn) in
the dorsal sac, while two control frogs were injected with the same
solution devoid of glucocorticoid. About 15 min later the four frogs
were again electrically stimulated, and the secretion was washed o¡
with 10 ml 0.1% acetic acid and freeze-dried. The protein content of
the secretion was determined using a Bio-Rad protein assay kit. Total
protein (100 Wg) from skin secretion was separated by 12% SDS-poly-
acrylamide gels (Bio-Rad), electroblotted on nitrocellulose (Sartorius)
and then blocked in TBST (50 mM Tris-HCl, pH 7.4, 100 mM NaCl,
0.1% Tween 20) containing 0.5% BSA. The membranes were incu-
bated for 16 h at 4‡C with 1:1000 dilution of polyclonal rabbit anti-
bodies against a synthetic peptide corresponding to the N-terminal
residues 26^39 of human IUBK (New England Biolabs Inc.). The blots
were washed and incubated with 1:2000 dilution of anti-rabbit Ig-
peroxidase conjugate in TBST. After several washes, antibody-reactive
bands were visualized by enhanced chemiluminescence (New England
Biolabs Inc.).
2.5. Bacteria-bath treatment of frogs
Nine wild frogs were divided into three groups. The ¢rst group was
bathed in 200 ml LB solution for 20 min. The second group was
bathed for 20 min in 200 ml of an overnight culture of Aeromonas
hydrophila diluted with fresh LB medium to 106 cells/ml. The third
group was injected intraperitoneally with 25 Wg methylprednisolone
(Solu-Medrol), left 15 min in a cage, then bathed for 20 min in the
bacteria solution as above. After 1 h, the nine frogs were electrically
stimulated, and the secretions were collected after washing each frog
with 20 ml 0.1% acetic acid. The secretions from each group of frogs
were pooled and 1 ml from each pool was fractionated by reversed-
phase HPLC as reported [17].
3. Results
3.1. Structure of the bombinin gene
Six clones, isolated from 5U105 recombinant phages of the
B. orientalis genomic library, were found to hybridize strongly
with the cDNA coding for the complete precursor of bomb-
inin [15]. The restriction maps of these clones, obtained by
digestion with several enzymes, indicated that each clone was
unique. Southern blotting analysis revealed that ¢ve of them
contained the same SacI-SacI 6.5-kb fragment. The 6.5-kb
fragment from clone B24 was subcloned in pBluescript and
sequenced. The full sequence of the gene (Fig. 1) includes 3733
bp and contains 555-bp 5P- and 551-bp 3P-untranslated re-
gions. Comparison with the published bombinin precursor
cDNA [16] reveals that the coding region of the gene consists
of two exons of 59 and 523 bp, respectively, interrupted by a
large intron of 2045 bp. Canonical GT/AG exon-intron junc-
tion sequences are found at the extremities of the intron [21].
The ¢rst exon encodes the ¢rst 20 amino acid residues, com-
prising the 18-residue signal peptide. Exon 2 contains the
remaining coding region (173 amino acid residues), which in-
cludes the acidic peptides 1 and 2, as reported by Gibson et al.
[16], two identical copies of a bombinin-like peptide (BLP-3)
and one copy of a C-terminal peptide, di¡erent from that
reported by Gibson [16]. This peptide is homologous to
bombinin H, antibacterial and/or hemolytic peptides found
in B. variegata [17]. It was therefore termed GH-1 (Gene-de-
rived bombinin H-like peptide). The 3P £anking region of the
gene includes three canonical polyadenylation sites (AA-
TAAA) centered at 66, 77 and 133 bp downstream of the
TAA stop codon, respectively. In the 5P untranslated region,
53 bp before the presumptive transcription start site, a TATA-
like box (TAAA) is located; another TATA box is centered at
3124 bp. This region is preceded by at least three CAAT
boxes (Fig. 1). Moreover, structural motifs for the binding
of transcription factors involved in the control of immune-
related molecules are found in the 5P £anking region: an
NFUB site centered at 3432 bp (negative orientation) and
an NF-IL6 site at 3473 bp (positive orientation) from the
translation initiation site.
Fig. 2 shows a schematic representation of the bombinin
gene with the restriction sites used in sequencing and cloning.
BLP-3 is almost identical (Leu in position 7 is substituted by
Ile) to the peptide described by Gibson as inactive [16]. We
have isolated BLP-3 from the skin secretion of B. orientalis,
following reversed-phase HPLC in the conditions described
previously for B. variegata [17]. It showed antibacterial activ-
ity towards a number of Gram-negative bacteria, the most
sensitive being the human pathogen Yersinia pseudotuberculo-
sis [22]. So far, peptides GH-1 and GH-2 have not been iso-
lated from the secretion. A synthetic GH-1 showed some anti-
bacterial and hemolytic activity. Neither the proparts 1 and 2
nor the two 8-residue spacer peptides have been isolated. They
may be rapidly broken down, perhaps as part of the process-
ing of the inactive precursor to the active e¡ector molecules.
The sixth clone (B9) was derived from a gene encoding
another bombinin precursor which was analyzed in part.
From a 15-kb SacI-SacI fragment, several sub-fragments
were obtained with digestion with HindIII (7, 3, 1.5 and
1 kb). Of these, the 1.5- and 1-kb sub-fragments strongly
hybridized with the bombinin cDNA [15], while the 3-kb
sub-fragment strongly hybridized with a probe containing
the promoter and the signal peptide region, obtained by suit-
able digestion of the ¢rst gene. Only the 1.5- and 1-kb sub-
fragments were sequenced, yielding an about 2500-bp stretch
which includes an intron of less than 2000 bp and a coding
region of about 380 bp. The exon codes for one copy of a
bombinin identical to that described as clone 7 in B. variegata
[15], and contains the information for a new C-terminal pep-
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Fig. 1. Sequence of the gene for BLP-3 and peptide GH-1. The two exons are given in uppercase, while non-coding regions are in lowercase.
The amino acid-deduced sequence is shown under the coding DNA, and mature peptide sequences are underlined. The gt/ag exon-intron junc-
tion sequence is boldfaced. The putative binding site for NFUB is underlined and the corresponding site for NF-IL6 is double underlined.
CAAT boxes in the 5P region as well as the polyadenylation sites in the 3P region are boldfaced. Putative TATA boxes are dot underlined and
boldfaced.
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tide, GH-2, with the deduced sequence ILGPVLDLV-
GRALRGLLKKIG. The terminal Gly is most likely used
for amidation of the penultimate Ile residue.
3.2. Gene control in vivo
In a previous paper [4], we reported on the e¡ect of gluco-
corticoids on the secretion of skin antimicrobial peptides in R.
esculenta. With that frog it was possible to treat the skin with
a glucocorticoid cream, which was applied to the whole sur-
face after having discharged the cutaneous glands by an elec-
trical stimulation. However, in the case of B. orientalis such a
treatment was not tolerated by the animal, which tried to
remove the cream both mechanically and by an abundant
secretion from the glands. Thus, GC treatment was performed
by injecting in the dorsal sac a suitable amount of methyl-
prednisolone, followed by electrical stimulation and collection
of the secretion. The e¡ect of the GC treatment was an in-
crease in the level of IUBK, which was detected directly in the
secretion by immunoblotting with anti-IUBK antibodies (Fig.
3). It is not surprising that IUBK is found in the secretion,
since granular cutaneous glands in B. orientalis release the
secretory materials through a holocrine mechanism [23].
As a test for function, we have induced the expression of
the bombinin genes in the live frogs by bathing them in bac-
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Fig. 4. Comparison of the peak areas of selected peptides (BLP-1
and BLP-3), taken as representative of antimicrobial peptides in the
skin secretion of B. orientalis [16]. The skin secretions from frogs
were lyophilized, dissolved in comparable amounts of 20% ethanol,
and fractionated on a reversed-phase column (Aquapore RP-300,
4.6U250 mm, Perkin Elmer), eluted with a suitable gradient of ace-
tonitrile/2-propanol 4:1 in 0.2% (v/v) tri£uoroacetic acid. Grey bars:
control frogs bathed in LB solution; black bars: frogs bathed in an
Aeromonas hydrophila LB solution; striped bars: frogs injected with
a glucocorticoid intraperitoneally and then bathed in an A. hydro-
phila LB solution.
Fig. 3. Western blot analysis of proteins from frog skin secretion.
Lane 1: control frog; lane 2: frog injected in the dorsal sac with a
glucocorticoid solution. Proteins were probed with an antibody
against human IUBK. The double band conforms to that reported in
the antibody kit (New England Biolabs Inc.). The arrow indicates
IUBK immunoreactivity.
Fig. 2. Schematic representation of the bombinin gene with the indication of restriction and promoter sites. Exon 1 contains the predicted sig-
nal sequence and two residues from propart 1 (RS). Exon 2 contains proparts 1^3, two 8-residue spacer peptides, two identical copies of BLP-
3 and the C-terminal peptide GH-1.
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teria-containing LB. This technique was ¢rst developed for R.
esculenta [24]. Here we bathed the frogs for 20 min in 200 ml
of an overnight culture of Aeromonas hydrophila. The control
bath was LB medium. After this treatment, the frogs were
electrically stimulated, skin secretions were collected and frac-
tionated by HPLC. The results are shown in Fig. 4, where the
peak areas of selected peptides (BLP-1 and BLP-3 [16]), taken
as representative of antimicrobial peptides in the secretion, are
reported for comparison. The short contact with bacteria was
su⁄cient to induce a marked increase in peptide synthesis in
the wild frogs, whereas the GC-treated frogs were unable to
increase the amount of bombinins in the secretion (Fig. 4).
4. Discussion
Most antibacterial peptides are derived from precursors
containing a single copy of the end-product, even though
clusters of genes can be found, as is the case with human
defensins [8,25] or insect cecropins [10]. However, cDNA
clones for the magainins from Xenopus laevis [26] and the
apidaecins from honeybee [27] have shown that peptide anti-
biotics sometimes are encoded in multiple copies in a single
gene. In case of apidaecins, a comparison was made to the
yeast pheromone and it was also suggested that multiple cop-
ies could be part of a regulatory device [27]. In the bombinin
gene of B. orientalis, the precursor is encoded in two exons,
the ¢rst containing the signal peptide and the second contain-
ing the information for three bioactive peptides interspersed
with proparts and spacer peptides. In addition, the sequence
of the exon from the second gene shows a high similarity with
the cDNAs encoding the bombinins from B. variegata, which
also contain the information for a single copy of both bomb-
inin and bombinin H [15].
The present study was undertaken to understand factors
that can up- or down-regulate the expression of the genes.
As a result of several attempts to infect R. esculenta with
Aeromonas hydrophila isolated from frog skin, we observed
that a bath in a suspension of live bacteria was most e¡ective
[24]. This method was therefore also used in this study with B.
orientalis. HPLC analysis of the skin secretions demonstrated
that exposure to bacteria resulted in a stimulation of bomb-
inin synthesis. This e¡ect was not observed with frogs which
had been injected with glucocorticoids (Fig. 4). The level of
antibacterial peptides in a wild animal is such to maintain a
balance between colonization and infection. The bacteria bath
represents an extreme condition, which stimulates the produc-
tion of antimicrobial peptides above the ‘constitutive’ level.
The bacterial challenge is not able to induce peptide synthesis
in glucocorticoid-treated animals, but the ‘constitutive’ level is
not a¡ected (Fig. 4). In addition, the Western blot analysis
shows that the injection of a glucocorticoid in the dorsal sac
of B. orientalis leads to a marked increase of IUBK (Fig. 3).
Here we show that the promoter region of the bombinin gene
contains recognition sites for nuclear factors (Fig. 1), such as
NFUB and NF-IL6 [28^30]. Previous studies on the frog genes
encoding PGLa, xenopsin, levitide and caerulein [31] were
reported without focusing on the promoter region. More re-
cently, two genes encoding the antimicrobial peptides derma-
septins from the arboreal frog Phyllomedusa bicolor were de-
scribed [32], but, as before, emphasis was on the processing of
the di¡erent precursors. Closer inspection of the published
sequence of the dermaseptin Drg1g2 gene [32] reveals the
presence of both these sites, centered at 3764 and 31177
bp upstream of the ATG initiation codon, respectively.
In conclusion, we have a new model system for host mi-
crobe infection. Simple exposure to bacteria results in gene
activation in the skin of frogs. It will be interesting to analyze
the intermediate steps in this chain of events.
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